133 related articles for article (PubMed ID: 8618588)
21. Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection.
Rehermann B; Lau D; Hoofnagle JH; Chisari FV
J Clin Invest; 1996 Apr; 97(7):1655-65. PubMed ID: 8601631
[TBL] [Abstract][Full Text] [Related]
22. Human lymphoblastoid interferon for the treatment of chronic hepatitis B. A randomized controlled trial.
Mazzella G; Saracco G; Rizetto M; Amed MA; Gonzàlez Quintela A; Rosina F; Barbara L; Roda E
Am J Med; 1988 Aug; 85(2A):141-2. PubMed ID: 3044077
[TBL] [Abstract][Full Text] [Related]
23. Repeated course of interferon treatment in chronic hepatitis B in childhood.
Giacchino R; Timitilli A; Cristina E; Giambartolomei G; Leonardi D; Caocci F; Cirillo C
Arch Virol Suppl; 1992; 4():273-6. PubMed ID: 1450700
[TBL] [Abstract][Full Text] [Related]
24. [Treatment of chronic hepatitis B with interferon alfa-2b (Intron A)].
Cianciara J; Laskus T; Hryniewicz H; Jabłońska J; Loch T
Przegl Epidemiol; 1991; 45(4):315-20. PubMed ID: 1841409
[TBL] [Abstract][Full Text] [Related]
25. Interferon alfa for chronic active hepatitis B. Long term follow-up of 62 patients: outcomes and predictors of response.
Hope RL; Weltman M; Dingley J; Fiatarone J; Hope AH; Craig PI; Grierson JM; Bilous M; Williams SJ; Farrell GC
Med J Aust; 1995 Jan; 162(1):8-11. PubMed ID: 7845310
[TBL] [Abstract][Full Text] [Related]
26. Hemolytic anemia secondary to interferon treatment for chronic B hepatitis.
Fornaciari G; Bassi C; Beltrami M; Castagnetti E; Maccari S; Plancher AC
J Clin Gastroenterol; 1991 Oct; 13(5):596-7. PubMed ID: 1744407
[No Abstract] [Full Text] [Related]
27. Treatment of fourteen chronic active HBsAg+, HBeAg+ hepatitis patients with low dose natural human interferon alpha administered orally.
Zielińska W; Paszkiewicz J; Korczak A; Własiuk M; Zółtowska A; Szutowicz A; Cummins JM; Georgiades JA
Arch Immunol Ther Exp (Warsz); 1993; 41(3-4):241-51. PubMed ID: 8129568
[TBL] [Abstract][Full Text] [Related]
28. [Severe exacerbation of chronic hepatitis B following interferon therapy].
Laskus T; Radkowski M; Cianciara J; Loch T; Slusarczyk J
Wiad Lek; 1992 Jun; 45(11-12):458-61. PubMed ID: 1441531
[TBL] [Abstract][Full Text] [Related]
29. Effect of recombinant alpha 2 interferon with or without prednisone in Chinese HBsAg carrier children.
Lai CL; Lin HJ; Lau JN; Flok AS; Wu PC; Chung HT; Wong LK; Leung MP; Yeung CY
Q J Med; 1991 Feb; 78(286):155-63. PubMed ID: 2031078
[TBL] [Abstract][Full Text] [Related]
30. Long-term versus short-term treatment with recombinant interferon alfa-2a in patients with chronic hepatitis B: a prospective, randomized treatment trial.
Rakela J; Wood JR; Czaja AJ; O'Brien PC; Taswell HF; Bowyer BA; Lange SM; Anderson ML; Parent K
Mayo Clin Proc; 1990 Oct; 65(10):1330-5. PubMed ID: 2214880
[TBL] [Abstract][Full Text] [Related]
31. [Chronic infection due to hepatitis B virus in patients less than 16 years of age: therapeutic approach by means of interferon alfa-2b].
Vetencourt R; Oropeza F; de Armas J; Cordero I; de Silva M; Machado I; Vetencourt M; Mendoza J
G E N; 1990; 44(4):353-60. PubMed ID: 2152277
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of chronic viral hepatitis B in children with moderate doses of alpha interferon].
Cullu F; Tümay GT; Kutlu T; Erkan T; Ozbay G; Badur S
Gastroenterol Clin Biol; 1995 Jan; 19(1):53-7. PubMed ID: 7720991
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of chronic viral hepatitis].
Marcellin P; Metreau JM; Pol S; Zoulim F
Ann Gastroenterol Hepatol (Paris); 1996; 32(2):85-7. PubMed ID: 8737503
[No Abstract] [Full Text] [Related]
34. Reactivation of hepatitis B virus infection induced by interferon (IFN) in HBsAg-positive, antiHCV-positive patients.
Villa E; Grottola A; Trande P; Seium Y; Rebecchi AM; Dugani A; Manenti F
Lancet; 1993 May; 341(8857):1413. PubMed ID: 7684479
[No Abstract] [Full Text] [Related]
35. The treatment of chronic viral hepatitis.
Hoofnagle JH; di Bisceglie AM
N Engl J Med; 1997 Jan; 336(5):347-56. PubMed ID: 9011789
[No Abstract] [Full Text] [Related]
36. A multicentre randomized clinical trial of recombinant alpha-2a interferon therapy in patients with chronic hepatitis B.
Rumi M; Romeo R; De Filippi F; Marcelli R; Del Ninno E; van Eyken P; Desmet V; Colombo M
Ital J Gastroenterol; 1993 Apr; 25(3):117-20. PubMed ID: 8507888
[TBL] [Abstract][Full Text] [Related]
37. Patients who do better do better.
Koretz RL
Gastroenterology; 1997 Apr; 112(4):1418-20. PubMed ID: 9098034
[No Abstract] [Full Text] [Related]
38. Transient hypothyroidism in a child treated with alpha-interferon for chronic hepatitis B infection.
Abdul-Jabbar MA; Ehrlich RM; Mann N; Roberts EA
Clin Pediatr (Phila); 1995 Dec; 34(12):663-5. PubMed ID: 8665748
[No Abstract] [Full Text] [Related]
39. [The treatment of hepatitis B and C with interferon-alpha can induce or aggravate psoriasis].
Cervoni JP; Serfaty L; Picard O; Imbert JC; Poupon R
Gastroenterol Clin Biol; 1995 Mar; 19(3):324-5. PubMed ID: 7781955
[No Abstract] [Full Text] [Related]
40. [Treatment of chronic hepatitis B and C with alpha interferon].
Hess G
Z Gastroenterol Verh; 1991 Mar; 26():149-51. PubMed ID: 1714130
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
